N,N-Morpholinyltryptamine
| mor-T | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 230.31 g/mol [1] |
| Predicted LogP | 2.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C14H18N2O |
| IUPAC name | 4-[2-(1H-indol-3-yl)ethyl]morpholine |
| SMILES | C1COCCN1CCC2=CNC3=CC=CC=C32 |
| InChI | InChI=1S/C14H18N2O/c1-2-4-14-13(3-1)12(11-15-14)5-6-16-7-9-17-10-8-16/h1-4,11,15H,5-10H2 |
| InChIKey | OITOJWZZJMQEAB-UHFFFAOYSA-N |
| CAS number | 25262-59-3 |
| PubChem CID | 213527 |
N,N-Morpholinyltryptamine (also known as 3-[2-(4-Morpholinyl)ethyl]indole, Db-137044, 3-[2-(morpholin-4-yl)ethyl]-1h-indole or 4-(2-(1H-Indol-3-yl)ethyl)morpholine) is a substance of the tryptamine and morpholinylethylindole class.
Chemistry
Stereochemistry []
N,N-Morpholinyltryptamine is achiral.
Druglikeness
Lipinski's rule of five
N,N-Morpholinyltryptamine matches Lipinski's rule of five.External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 213527, N,N-Morpholinyltryptamine. Accessed November 22, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/213527
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 12:24:32 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 12:24:27 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 12:24:28 |
| gsrs | missing (no UNII) | 2026-11-20 12:24:27 |
| hmdb | missing (no HMDB id) | 2026-11-20 12:24:28 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 12:24:32 |
| pubchem | ok | 2026-11-20 12:24:27 |
| missing (no r/tripreports posts mention it) | 2026-11-20 12:24:27 | |
| sider | missing (not in SIDER) | 2026-11-20 12:24:27 |
| structure | ok | 2026-11-20 12:24:27 |
| wikipedia | missing (no Wikipedia article with a drug infobox) | 2026-11-20 12:24:28 |